Jeno Gyuris is SVP & Chief Scientific Officer at AVEO PHARMACEUTICALS INC (AVEO). They have made 6 open-market trades across 1 company since 2012, most recently 2015-01-07.
CIK 0001486359
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AVEO | 76,131 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2015-01-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVEO | SELL · 10b5-1 | 2015-01-07 | 2015-01-08 | $0.80 | $4K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL · 10b5-1 | 2014-01-30 | 2014-01-30 | $1.64 | $9K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL · 10b5-1 | 2013-01-28 | 2013-01-28 | $7.77 | $6K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL | 2012-05-05 | 2012-03-07 | $— | — | -20.0% | +0.8% | +0.8% |
| AVEO | SELL | 2012-03-08 | 2012-03-12 | $13.07 | $26K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL | 2012-03-05 | 2012-03-13 | $13.10 | $66K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL | 2012-02-29 | 2012-03-02 | $13.23 | $67K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL | 2012-02-24 | 2012-02-28 | $13.44 | $34K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL | 2012-02-23 | 2012-02-24 | $13.50 | $7K | -20.0% | +0.8% | +0.8% |
| AVEO | SELL · 10b5-1 | 2012-01-26 | 2012-01-30 | $13.37 | $10K | -20.0% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.